Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
Détails
ID Serval
serval:BIB_234F2E8B1BDE
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
Périodique
British journal of haematology
ISSN
0007-1048 (Print)
ISSN-L
0007-1048
Statut éditorial
Publié
Date de publication
10/2007
Peer-reviewed
Oui
Volume
139
Numéro
1
Pages
159-161
Langue
anglais
Notes
Publication types: Case Reports ; Journal Article ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Publication Status: ppublish
Mots-clé
Acute Disease, Antigens, Human Platelet/immunology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Female, HLA Antigens/immunology, Hematopoietic Stem Cell Transplantation, Humans, Isoantibodies/analysis, Leukemia, Myeloid/immunology, Leukemia, Myeloid/therapy, Middle Aged, Platelet Transfusion, Transplantation, Homologous, Treatment Failure
Pubmed
Web of science
Création de la notice
01/11/2019 11:31
Dernière modification de la notice
02/11/2019 7:26
Données d'usage
